http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102013032411-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_054408286b7975436cc2e1f4b7917dcc |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
| filingDate | 2013-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f246757b0b29b6ddc8a04a991e8d369e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f116935ee0a61da6f80ae2ec26229e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ed24449938244c207f2ed13ba93571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aea6e7ead09ff242d9f3a34835c64cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ec1d1145e01253d7ba6dc2874a8488 |
| publicationDate | 2022-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102013032411-B1 |
| titleOfInvention | PROCESS FOR OBTAINING A FIBRINOLYTIC ENZIN FROM THE MICROALGAE CHLORELLA VULGARIS |
| abstract | PROCESS OF OBTAINING A FIBRINOLYTIC ENZYME FROM THE MICROALGAE Chlorella vulgaris Thrombosis is a disease characterized by the appearance of a blood clot - the thrombus - in a vessel of the blood system, which determines partial or total obstruction and prevents local circulation . It is estimated that 50 cases of thrombosis occur per 100,000 inhabitants. The treatment of thrombosis is done in a hospital environment, with the application of anticoagulants intravenously, in high doses, to reduce blood viscosity, dissolve the clot, prevent the occurrence of pulmonary embolism and prevent the formation of a new thrombus. Commercial thrombolytic agents are expensive and their main disadvantage is the occurrence of internal bleeding. This is because they do not have a specific action on the clot, but rather a general action on the blood system. In this sense, it is important not only to reduce the costs of producing fibrinolytic enzymes that act on the clots, but also to develop a therapy for the local application of the enzyme. The present invention relates to the process of obtaining an enzyme with fibrinolytic and fibrinogenolytic activity for pharmacological use using the photosynthetic microorganism, Chlorella vulgaris. |
| priorityDate | 2013-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.